Hims & Hers Health, Inc. · NYSE:HIMS
Hims & Hers Health — Q3 2022 Earnings Presentation
21 slides from Hims & Hers Health's earnings presentation, Nov 7, 2022
Slide 1: Third Quarter 2022 Financial Results Supplemental Presentation
Slide 2: Disclaimer
Disclaimer ‘This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act af 1933, as amanded and Section 21E of the Sacuritias Exchange Act of 1934, as amended. These forwar looking statements con be idontitied by the use of forward-locking terminolog
Slide 3: Q3 2022 Earnings
himszhers Q3 2022 Earnings Revenue Growth $144.8M 95% increase vs prior year 90%+ recurring subscription revenue Patient Impact 991k membership subscriptions +174k vs prior quarter 8.8M medical consultations since launch Tech & Platform Operational Excellence a Launched both Hims 5 Record subscripti
Slide 4: Differentiated
Differentiated
Slide 5: The frictionless experience modern consumers expect
ilar treat Shampee der @ “> Double Dore Sleep: Supplement The frictionless experience modern consumers expect, making health and wellness more accessible than ever... oat Care The support you need, when you needit Welcome back, 2 Add treatment ‘Our most popular programs (improves texture Erectile Pr
Slide 6: Powered by a digitally native, fully verticalized end-to-end experience
.. powered by a digitally native, fully verticalized end-to-end experience Brand Technology Experience v Trusted Consumer Brand World-Class Providers Innovative Formulations Personalized Platform Cloud Pharmacy Seamless Delivery
Slide 7: Innovation
Innovation Through innovation and normalization we build long-lasting customer relationships Seamless Experience himszhers 7
Slide 8: Our technology platform powers 24/7 care, original content and 1-click shopping
Our technology platform powers 24/7 care, original content and 1-click shopping, broadening value-added services for Members e@eee89 24/7 Concierge services Integrated health records Secure provider messaging Modern, proprietary EMR National provider & partner network Guided Programs lead by physici
Slide 9: Enhanced customization with Hims and Hers Apps
Enhanced customization with Hims and Hers Apps, offering exclusive content and offerings \ with the Your order was placed. ae as 4 = Preview M hms «hers 4.8 otk ok Preview Care made convenient nun weenie Htems Goodnight Wrinkle Night Cream Mind Unwind Calming Drops.
Slide 10: Strong adoption, growth and a trusted brand backed by scalable operational capabilities
Strong adoption, growth and a trusted brand backed by scalable operational capabilities unlocks our seamless experience and future offerings Columbus, OH @ 300k sq. ft. Columbus a SL @ Secure regulation standard drug \ OH 4 storage cage @ Fullautomation packaging machinery Phoenix AZ © 2k sq. ft. @
Slide 11: We've seen rapid uptick in adoption across our platform
We've seen rapid uptick in adoption across our platform — a.m 33.3M+ >53k Cumulative patient Quality control provider touchpoints' chart reviews 5.2M 1.2M 8.8M medical consultations since launch 431k 18 19 "20 "21 Q3'22
Slide 12: Significant historical revenue growth + gross margin profile
Significant historical revenue growth + gross margin profile translates to attractive gross profit generation Year-over-Year Growth % --— 4 209% 4 80% a 83% id $272 Annual revenue (S millions) 117% \ CAGR $149 FY 2018 FY 2019 FY 2020 FY 2021 Gross Margin % 29% 54% 74% 75% a $204 Annual gross profit
Slide 13: Expanding customer base has driven both new and repeat revenue
Expanding customer base has driven both new and repeat revenue q 609 ie $247 @ @ New Revenue’ o We “ 67% - Repeat Customer "19-21CAGR* Revenue? bs Subscriptions 66% r on o "9-21 CAGR : . _ 81% es ye” BZICAGR $141 . 312 os $82 190 134 wl EOY 2018 EOY 2019 EOY 2020 EOY 2021 FY 2018 FY 2019 FY 2020 FY
Slide 14: Subscription expansion driving strong revenue growth
Subscription expansion driving strong revenue growth +80% Q3'22 YoY Subscriptions (000s) 991 817 710 609 551 453 391 283 312 258 192 195 190 218 i r i F r Q119 Q2’19 Q3’19 Q419 Q1’20 Q2’20 Q3’'20.Q4’20 QI’'21 Q2'21 Q3’21 Q4’21 QI’22 Q2'22 Q3'22 $145 Quarterly revenue ($ millions) +95% sna Q3'22 YoY
Slide 15: Adj. EBITDA profitability expected in 4Q
Adj. EBITDA profitability expected in 4Q +9.0%
Slide 16: Underlying themes for 2022 outlook
Long Term Retention 85%+ Online revenue retention from subscriptions with a tenure of at least 2 years Underlying themes for 2022 outlook Strong Unit Economics <lyr. Less than 1 year payback period’ on marketing investments Category Expansion Continued scaling of emerging categories’ Progressive Mar
Slide 17: 2022 FY and Q4 outlook
2022 FY and Q4 outlook Q4 2022E
Slide 18: Non-GAAP Financial Measures
Non-GAAP Financial Measures In addition to our Financial results determined in accordonce with US. GAAP, we prasent Adjusted EBITDA (which is a non-GAAP measure) and Adjusted EBITDA margin (which fs a non-GAAP margin), each as dafined below. We use Adjusied EBITDA and Adjusted EBITDA margin to evalu
Slide 19: Reconciliation of Non-GAAP financial measures
Reconci ($ millions, unaudited) Revenue Net Loss Stock-based compensation Acquisition-related costs Merger bonuses Depreciation and amortization Warrant expenses in connection with Merger Amortization of debt issuance costs Interest expense Interest income Provision (benefit) for income taxes Change
Slide 20: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures ($ millions, unaudited) Revenue Net Loss Stock-based compensation Depreciation and amortization Impairment of long-lived assets Provision (benefit) for income taxes Acquisition-related costs Change in fair value of liabilities Interest income Merger bonu
Slide 21: Slide 21